OIM
BHVN
Oracle Investment Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,240,932
| Closed | -$181M | – | 30 |
|
|
2022
Q2 | $181M | Sell |
1,240,932
-820,470
| -40% | -$120M | 54.93% | 1 |
|
|
2022
Q1 | $244M | Sell |
2,061,402
-14,000
| -0.7% | -$1.66M | 48.33% | 1 |
|
|
2021
Q4 | $286M | Sell |
2,075,402
-48,653
| -2% | -$6.7M | 40.64% | 1 |
|
|
2021
Q3 | $295M | Buy |
2,124,055
+41,500
| +2% | +$5.76M | 36.73% | 1 |
|
|
2021
Q2 | $202M | Sell |
2,082,555
-40,716
| -2% | -$3.95M | 27.86% | 1 |
|
|
2021
Q1 | $145M | Sell |
2,123,271
-25,000
| -1% | -$1.71M | 21.73% | 1 |
|
|
2020
Q4 | $184M | Buy |
2,148,271
+73,471
| +4% | +$6.3M | 23.07% | 2 |
|
|
2020
Q3 | $135M | Buy |
2,074,800
+63,100
| +3% | +$4.1M | 17.77% | 2 |
|
|
2020
Q2 | $147M | Buy |
2,011,700
+140,957
| +8% | +$10.3M | 18.66% | 2 |
|
|
2020
Q1 | $63.7M | Sell |
1,870,743
-52,547
| -3% | -$1.79M | 18.91% | 2 |
|
|
2019
Q4 | $105M | Buy |
1,923,290
+143,415
| +8% | +$7.81M | 19.66% | 3 |
|
|
2019
Q3 | $74.3M | Buy |
1,779,875
+106,925
| +6% | +$4.46M | 18.26% | 4 |
|
|
2019
Q2 | $73.3M | Buy |
1,672,950
+651,558
| +64% | +$28.5M | 15.76% | 4 |
|
|
2019
Q1 | $52.6M | Buy |
1,021,392
+846,857
| +485% | +$43.6M | 11.19% | 4 |
|
|
2018
Q4 | $6.45M | Buy |
+174,535
| New | +$6.45M | 2% | 9 |
|